Elizabeth H.Z. Thompson Horizon Therapeutics Public LTD CO (HZNP) insider trading activity

Elizabeth H.Z. Thompson is EVP, Research & Development of Horizon Therapeutics Public Ltd Co. Currently has a direct ownership of 0 shares of HZNP, which is worth approximately $0. The most recent transaction as insider was on Oct 06, 2023, when has been sold 14,575 shares (Ordinary Shares) at a price of $116.5 per share, resulting in proceeds of $1,697,987. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Elizabeth H.Z. Thompson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 06 2023	SELL Sale (or disposition) back to the issuer	$1,697,987 $116.5 p/Share	14,575 Reduced 100.0%	0 Ordinary Shares
Mar 13 2023	SELL Bona fide gift	-	2,000 Reduced 12.07%	14,575 Common Stock
Dec 30 2022	SELL Payment of exercise price or tax liability	$1,075,296 $113.8 p/Share	9,449 Reduced 36.31%	16,575 Ordinary Shares
Dec 30 2022	BUY Exercise of conversion of derivative security	-	19,055 Added 42.27%	26,024 Ordinary Shares
Jul 20 2022	SELL Open market or private sale	$502,945 $85.0 p/Share	5,917 Reduced 45.92%	6,969 Ordinary Shares
Jul 19 2022	SELL Open market or private sale	$7,653 $85.03 p/Share	90 Reduced 0.69%	12,886 Ordinary Shares
Jul 07 2022	SELL Open market or private sale	$6,971 $85.01 p/Share	82 Reduced 0.63%	12,976 Ordinary Shares
Apr 18 2022	SELL Open market or private sale	$936,453 $115.64 p/Share	8,098 Reduced 38.28%	13,058 Ordinary Shares
Jan 05 2022	SELL Payment of exercise price or tax liability	$715,935 $101.84 p/Share	7,030 Reduced 24.94%	21,156 Ordinary Shares
Jan 05 2022	BUY Exercise of conversion of derivative security	-	13,999 Added 33.18%	28,186 Ordinary Shares
Aug 05 2021	SELL Open market or private sale	$802,016 $106.34 p/Share	7,542 Reduced 34.71%	14,187 Ordinary Shares
Jul 01 2021	SELL Payment of exercise price or tax liability	$578,381 $96.59 p/Share	5,988 Reduced 21.6%	21,729 Ordinary Shares
Jul 01 2021	BUY Exercise of conversion of derivative security	-	12,077 Added 30.35%	27,717 Ordinary Shares

Also insider at

ACAD

ACADIA PHARMACEUTICALS INC Healthcare

EVP, Head of Research & Dev

IGMS

IGM Biosciences, Inc. Healthcare

EHT